Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Treatment of varicella (chickenpox) infection

Mary A Albrecht, MD
Section Editors
Martin S Hirsch, MD
Morven S Edwards, MD
Deputy Editors
Jennifer Mitty, MD, MPH
Mary M Torchia, MD


Varicella-zoster virus (VZV) is one of eight herpesviruses known to cause human infection and is distributed worldwide. Primary infection with VZV causes varicella (chickenpox) in susceptible hosts. Most healthy children have self-limited infection with primary varicella. However, varicella can cause severe complications such as soft tissue infection, pneumonia, hepatitis, Reye syndrome, and encephalitis. Patients at increased risk of complications include adolescents, adults, pregnant women, and immunocompromised hosts.

The treatment of primary varicella infection will be reviewed here. Issues related to the transmission, clinical manifestations, and complications of varicella, as well as the management of pregnant women and neonates, are discussed separately. (See "Clinical features of varicella-zoster virus infection: Chickenpox" and "Varicella-zoster virus infection in pregnancy" and "Varicella-zoster infection in the newborn".)


Patients with varicella typically develop a fever and a vesicular rash that is pruritic. Many patients require supportive care to manage these symptoms. (See 'Supportive care' below.)

The decision to initiate antiviral therapy depends upon the patient’s age, the presence or absence of comorbid conditions, and the patient’s clinical presentation. Although varicella is usually a self-limited disease, if complications develop, they can be life-threatening. (See "Clinical features of varicella-zoster virus infection: Chickenpox", section on 'Complications of varicella'.)

Our approach to antiviral therapy is as follows (see 'Individuals without complications' below and 'Individuals with complications' below):


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Feb 2, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34:434.
  2. Lesko SM, O'Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107:1108.
  3. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999; 340:1377.
  4. Dunkle LM, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med 1991; 325:1539.
  5. Wallace MR, Bowler WA, Murray NB, et al. Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann Intern Med 1992; 117:358.
  6. Feder HM Jr. Treatment of adult chickenpox with oral acyclovir. Arch Intern Med 1990; 150:2061.
  7. Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis 1988; 157:309.
  8. Ogilvie MM. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36 Suppl 1:31.
  9. Cunha BA, Baron J. The pharmacokinetic basis of oral valacyclovir treatment of herpes simplex virus (HSV) or varicella zoster virus (VZV) meningitis, meningoencephalitis or encephalitis in adults. J Chemother 2015; :1973947815Y0000000065.
  10. Yu H, Zhu QR, Wang ZL, et al. [Randomized controlled multi-center trial for treatment of varicella in pediatric patients with hydrochloride valacyclovir]. Zhonghua Er Ke Za Zhi 2008; 46:454.
  11. Canadian Agency for Drugs and Technologies in Health. Acyclovir versus Valacyclovir for Herpes Virus in Children and Pregnant Women: A Review of the Clinical Evidence and Guidelines. September 5 2014
  12. Biron KK, Elion GB. In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob Agents Chemother 1980; 18:443.
  13. Drugs for non-HIV viral infections. Treat Guidel Med Lett 2005; 3:23.
  14. American Academy of Pediatrics. Varicella-zoster infections. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.846.
  15. Kesson AM, Grimwood K, Burgess MA, et al. Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy. J Paediatr Child Health 1996; 32:211.
  16. Marin M, Watson TL, Chaves SS, et al. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis 2008; 197 Suppl 2:S94.
  17. Balfour HH Jr, Rotbart HA, Feldman S, et al. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr 1992; 120:627.
  18. Heininger U, Seward JF. Varicella. Lancet 2006; 368:1365.
  19. Klassen TP, Hartling L, Wiebe N, Belseck EM. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database Syst Rev 2005; :CD002980.
  20. Balfour HH Jr, Kelly JM, Suarez CS, et al. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr 1990; 116:633.
  21. Balfour HH Jr, Edelman CK, Anderson RS, et al. Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance. Pediatr Infect Dis J 2001; 20:919.
  22. Kechagia IA, Kalantzi L, Dokoumetzidis A. Extrapolation of Valacyclovir Posology to Children Based on Pharmacokinetic Modeling. Pediatr Infect Dis J 2015; 34:1342.
  23. American Academy of Pediatrics. Non-HIV antiviral drugs. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, 2015. p.919.
  24. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995; 172:706.
  25. Centers for Disease Control and Prevention (CDC). Varicella-related deaths among adults--United States, 1997. MMWR Morb Mortal Wkly Rep 1997; 46:409.
  26. Miller E, Vardien J, Farrington P. Shift in age in chickenpox. Lancet 1993; 341:308.
  27. Hill G, Chauvenet AR, Lovato J, McLean TW. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia. Pediatrics 2005; 116:e525.
  28. Straus SE, Ostrove JM, Inchauspé G, et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108:221.
  29. Prober CG, Kirk LE, Keeney RE. Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study. J Pediatr 1982; 101:622.
  30. Haake DA, Zakowski PC, Haake DL, Bryson YJ. Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis 1990; 12:788.
  31. Tojimbara T, So SK, Cox KL, et al. Fulminant hepatic failure following varicella-zoster infection in a child. A case report of successful treatment with liver transplantation and perioperative acyclovir. Transplantation 1995; 60:1052.
  32. Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002; 186 Suppl 1:S91.
  33. Lee S, Ito N, Inagaki T, et al. Fulminant varicella infection complicated with acute respiratory distress syndrome, and disseminated intravascular coagulation in an immunocompetent young adult. Intern Med 2004; 43:1205.
  34. Frangides CY, Pneumatikos I. Varicella-zoster virus pneumonia in adults: report of 14 cases and review of the literature. Eur J Intern Med 2004; 15:364.
  35. Roque-Afonso AM, Bralet MP, Ichai P, et al. Chickenpox-associated fulminant hepatitis that led to liver transplantation in a 63-year-old woman. Liver Transpl 2008; 14:1309.
  36. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303.